Artificial intelligence has the potential to transform healthcare, but in medical devices, innovation must be balanced with an unwavering commitment to patient safety. Drawing from years of experience leading software development for surgical safety platforms, the author explores how successful AI adoption depends not only on technological advancement, but also on rigorous validation, regulatory compliance, cybersecurity, and high-quality data. As AI becomes increasingly integrated into clinical environments, organizations that prioritize trust, transparency, and safety will be best positioned to deliver meaningful improvements in patient outcomes.

I’m excited to share my professional biography, which reflects over 30 years of experience in pharma, biopharma, and FDA-regulated industries. My career has been dedicated to bridging scientific innovation with strategic market growth, leading cross-functional global teams, and driving measurable results in highly regulated environments. As I continue to explore part-time board and advisory opportunities, I look forward to contributing my expertise to organizations seeking strategic guidance and global perspective.

I’m a pharmacist and consultant with over 25 years of experience spanning the pharmaceutical industry, regulatory affairs, and academia. My career has been driven by a passion for translating complex regulatory requirements into clear, actionable strategies that help companies innovate responsibly. Through leadership roles in both industry and consulting, I’ve had the privilege of mentoring professionals, teaching at top pharmacy schools, and partnering with organizations to align science, compliance, and strategic growth. I’m always excited to connect with others who are committed to elevating healthcare and advancing thoughtful, compliant innovation.

Quynh Ton is a dedicated and resilient molecular and cellular developmental biologist with over 10 years of experience in the biotech industry. Known for her integrity and commitment to improving patient care, Quynh combines her extensive knowledge in drug discovery, gene therapy, and antibody development with a proven track record in business development. She has successfully secured significant contracts, demonstrating her strategic acumen and ability to drive initiatives within her field. Quynh's exceptional communication skills enable her to convey complex scientific concepts clearly, fostering collaboration across diverse teams and stakeholders. Her passion for advancing scientific knowledge and delivering impactful solutions positions her as a valuable asset in any organization.